SAN DIEGO and CALGARY, AB, April 10, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, has entered into a share purchase agreement (SPA) with Alumni Capital LP (Alumni), an institutional...
Read More Details
Finally We wish PressBee provided you with enough information of ( Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital )
Also on site :
- Ver lo invisible: cómo la termografía Raytron potencia la protección de la fauna salvaje en todo el mundo
- Voir l'invisible : L'imagerie thermique Raytron au service de la protection de la faune dans le monde
- How to pick the best travel insurance